Overview
BrainVTA (Wuhan) Co., Ltd. was established in 2014 in Wuhan Optics Valley, China. Since its establishment 10 years ago, BrainVTA has been dedicated to virus vector technology and translational medical research services. We have provided high-quality, efficient, and cutting-edge viral tools and technical support services to over 200 pharmaceutical companies, 600+ top research groups, and 3,000+ scientific researchers both at home and abroad. As a result, our clients have published over 900 high-quality articles. Our high-quality viral vector products and experimental research services are available in translational medicine fields such as neuroscience, neurological diseases, gene function research, genetic diseases, gene therapy, tumors, and stem cell therapy, etc., and have gained high recognition from frontline researchers
What We Do
We offer both research-grade and cGMP-grade AAV, lentivirus-based products and custom services. Rabies viruses (RV), Pseudorabies viruses (PRV), Herpes simplex viruses (HSV) and Vesicular stomatitis virus (VSV) can also be offered, but only for research-grade. Since we was founded, Over 20000+ customized AAV vectors with the highest quality have been offered to support research projects in privately held companies, university labs, and non-profit institutions worldwide
Building Success through Experience
Experience Matters:
Over 5 years in business with a focus on high-quality products.
Customer-Centric Approach:
Built on lasting relationships and effective promotion.
Exclusive Collaboration:
Seeks exclusive partnerships within designated territories.
Shared Values:
Prefers partners with a genuine commitment to customer welfare.